AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27073975 — intervention group
Group type: EXPERIMENTAL
Intervention: Family requests for early withdrawal of life support
Number of subjects: 0
Study 27073975 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication gaps related to prognostic uncertainty
Number of subjects: 0
Study 24275233 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp incision with scissors
Number of subjects: 34
Study 24275233 — intervention group
Group type: EXPERIMENTAL
Intervention: Blunt manual cleavage of the fascia
Number of subjects: 34
Study 24275233 — intervention group
Group type: COMPARATOR
Intervention: Pain scores
Number of subjects: 34
Study 22561092 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 0
Study 22561092 — intervention group
Group type: COMPARATOR
Intervention: Contact Control (CC)
Number of subjects: 0
Study 20421229 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump CABG
Number of subjects: 32
Study 20421229 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 32
Study 17700438 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy added to general practitioners' care
Number of subjects: 135
Study 17700438 — intervention group
Group type: COMPARATOR
Intervention: General practitioners' care alone
Number of subjects: 135
Study 16292118 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 52
Study 16292118 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 52
Study 12183711 — intervention group
Group type: EXPERIMENTAL
Intervention: Organized lipid matrix (OLM)
Number of subjects: 76
Study 12183711 — intervention group
Group type: COMPARATOR
Intervention: Triacylglycerol (TG)
Number of subjects: 76
Study 10190520 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide‐isoproterenol test
Number of subjects: 96
Study 10190520 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol test
Number of subjects: 96
Study 10190520 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 96
Study 8942589 — intervention group
Group type: EXPERIMENTAL
Intervention: IV droperidol 1.25 mg and ondansetron 4 mg
Number of subjects: 120
Study 8942589 — intervention group
Group type: COMPARATOR
Intervention: IV droperidol 1.25 mg and saline
Number of subjects: 120
Study 2039720 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 8‐methoxypsoralen photochemotherapy (PUVA) using ultraviolet fluorescent lamps with peak emission at 325 nm
Number of subjects: 24
Study 2039720 — intervention group
Group type: COMPARATOR
Intervention: Oral 8‐methoxypsoralen photochemotherapy (PUVA) using ultraviolet fluorescent lamps with peak emission at 352 nm
Number of subjects: 24
Study 2039720 — intervention group
Group type: COMPARATOR
Intervention: Oral 8‐methoxypsoralen photochemotherapy (PUVA) using ultraviolet fluorescent lamps with peak emission at 370 nm
Number of subjects: 24
Study 7129805 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg nomifensine intravenously
Number of subjects: 10
Study 7129805 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg nomifensine orally
Number of subjects: 10
Study 7129805 — intervention group
Group type: COMPARATOR
Intervention: 75 mg nomifensine orally
Number of subjects: 10
Study 7129805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7129805 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine (both forms)
Number of subjects: 10
Study 7129805 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 10
Study 31624048 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz cerebellar repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 23
Study 31624048 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study 31520608 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygroscopic dilators with misoprostol 400 mcg
Number of subjects: 163
Study 31520608 — intervention group
Group type: COMPARATOR
Intervention: No hygroscopic dilators with misoprostol 400 mcg
Number of subjects: 163
Study 31520608 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal misoprostol
Number of subjects: 163
Study 31520608 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol
Number of subjects: 163
Study 28676254 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation by two bilingual lay navigators providing individualized education and support
Number of subjects: 843
Study 28676254 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 843
Study 28676254 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation
Number of subjects: 843
Study 26553689 — intervention group
Group type: EXPERIMENTAL
Intervention: PsA‐TT
Number of subjects: 0
Study 26553689 — intervention group
Group type: COMPARATOR
Intervention: PsACWY
Number of subjects: 0
Study 26553689 — intervention group
Group type: EXPERIMENTAL
Intervention: PsA‐TT (2 doses)
Number of subjects: 0
Study 23732344 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry monitoring
Number of subjects: 167
Study 23732344 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 167
Study 21175981 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion (Actrapid 2 IU/h) during dialysis
Number of subjects: 11
Study 21175981 — intervention group
Group type: COMPARATOR
Intervention: Conventional dialysis
Number of subjects: 11
Study 19140915 — intervention group
Group type: EXPERIMENTAL
Intervention: Sums of the amplitudes of the ECG QRS complexes from leads I and II
Number of subjects: 20
Study 19140915 — intervention group
Group type: EXPERIMENTAL
Intervention: Sums of the amplitudes of the six limb leads
Number of subjects: 20
Study 19140915 — intervention group
Group type: EXPERIMENTAL
Intervention: Sums of the amplitudes of the V1-V6 leads
Number of subjects: 20
Study 19140915 — intervention group
Group type: EXPERIMENTAL
Intervention: Sums of the amplitudes of all 12 leads
Number of subjects: 20
Study 17197581 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT (tension-free vaginal tape) procedure
Number of subjects: 267
Study 17197581 — intervention group
Group type: COMPARATOR
Intervention: TVT-O (transobturator tension-free vaginal tape) procedure
Number of subjects: 267
Study 15095806 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual, and vestibular (ATVV) multisensory intervention twice daily from 33 weeks postconceptional age until hospital discharge
Number of subjects: 37
Study 15095806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no multisensory intervention)
Number of subjects: 37
Study 15095806 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual, and vestibular (ATVV) multisensory intervention
Number of subjects: 37
Study 11407078 — intervention group
Group type: EXPERIMENTAL
Intervention: BioHy (high molecular weight hyaluronic acid)
Number of subjects: 0
Study 11407078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9921004 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin
Number of subjects: 97
Study 9921004 — intervention group
Group type: EXPERIMENTAL
Intervention: Aurothiomalate
Number of subjects: 97
Study 9921004 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 97
Study 9480464 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes mellitus (IDDM)
Number of subjects: 54
Study 9480464 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 54
Study 2198303 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (15 mg/day, titrated to a maximum of 90 mg/day)
Number of subjects: 382
Study 2198303 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (40 mg/day)
Number of subjects: 382
Study 2198303 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepirone (analogue of buspirone)
Number of subjects: 382
Study 2198303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study 572722 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined carbohydrate diet
Number of subjects: 18
Study 572722 — intervention group
Group type: COMPARATOR
Intervention: Standardised diet with low refined carbohydrate
Number of subjects: 18
Study 30409085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with 3-4 daily serves of dairy food (MedDairy)
Number of subjects: 41
Study 30409085 — intervention group
Group type: COMPARATOR
Intervention: Low-fat (LF) control diet
Number of subjects: 41
Study 30905230 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil (20 mL/d)
Number of subjects: 19
Study 30905230 — intervention group
Group type: EXPERIMENTAL
Intervention: Amaranth oil (20 mL/d)
Number of subjects: 19
Study 30905230 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 19
Study 28422805 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 21
Study 28422805 — intervention group
Group type: COMPARATOR
Intervention: Methohexital
Number of subjects: 21
Study 27533976 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4547
Study 27533976 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 4547
Study 24057101 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg/kg intravenous before anesthesia)
Number of subjects: 110
Study 24057101 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone)
Number of subjects: 110
Study 22101698 — intervention group
Group type: EXPERIMENTAL
Intervention: ELP (Bo-gu Ling)
Number of subjects: 150
Study 22101698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 19258378 — intervention group
Group type: EXPERIMENTAL
Intervention: Training GPs
Number of subjects: 200
Study 19258378 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine
Number of subjects: 200
Study 19258378 — intervention group
Group type: COMPARATOR
Intervention: Cortisone
Number of subjects: 200
Study 17695602 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyract Flow
Number of subjects: 37
Study 17695602 — intervention group
Group type: EXPERIMENTAL
Intervention: Admira Flow
Number of subjects: 37
Study 17695602 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Flow
Number of subjects: 37
Study 17695602 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z250
Number of subjects: 37
Study 17695602 — intervention group
Group type: COMPARATOR
Intervention: All materials tested
Number of subjects: 37
Study 15223498 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial healing rates calculated by method 1
Number of subjects: 17
Study 15223498 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial healing rates calculated by method 2
Number of subjects: 17
Study 15223498 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative initial healing rates
Number of subjects: 17
Study 15223498 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial healing rates (both methods)
Number of subjects: 17
Study 11317194 — intervention group
Group type: EXPERIMENTAL
Intervention: COER-verapamil (180-540 mg at bedtime)
Number of subjects: 281
Study 11317194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 11317194 — intervention group
Group type: EXPERIMENTAL
Intervention: COER-verapamil
Number of subjects: 281
Study 9496925 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental gum (2.5% alpha-tricalcium-phosphate)
Number of subjects: 14
Study 9496925 — intervention group
Group type: COMPARATOR
Intervention: Control gum
Number of subjects: 14
Study 7805631 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral family-based treatment targeting parents and children for weight loss
Number of subjects: 0
Study 7805631 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle or aerobic exercise
Number of subjects: 0
Study 7805631 — intervention group
Group type: COMPARATOR
Intervention: Nontargeted controls
Number of subjects: 0
Study 7805631 — intervention group
Group type: COMPARATOR
Intervention: Calisthenics control
Number of subjects: 0
Study 3362176 — intervention group
Group type: EXPERIMENTAL
Intervention: High-stearic-acid diet
Number of subjects: 11
Study 3362176 — intervention group
Group type: EXPERIMENTAL
Intervention: High-oleic-acid diet
Number of subjects: 11
Study 3362176 — intervention group
Group type: COMPARATOR
Intervention: High-palmitic-acid diet
Number of subjects: 11
Study 30555165 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasdegib plus low-dose cytarabine (LDAC)
Number of subjects: 132
Study 30555165 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cytarabine (LDAC) alone
Number of subjects: 132
Study 29081267 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (≥60 seconds after delivery)
Number of subjects: 1566
Study 29081267 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (≤10 seconds after delivery)
Number of subjects: 1566
Study 29081267 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping
Number of subjects: 1566
Study 29081267 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping
Number of subjects: 1566
Study 26160319 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane-fentanyl anaesthesia
Number of subjects: 80
Study 26160319 — intervention group
Group type: COMPARATOR
Intervention: Intravenous midazolam-fentanyl anaesthesia (Control)
Number of subjects: 80
Study 23173759 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention including patient interview about rehabilitation, comprehensive information to GP about individual needs, encouragement for GP to contact patient proactively
Number of subjects: 955
Study 23173759 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual procedures)
Number of subjects: 955
Study 21821568 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based subsidies
Number of subjects: 0
Study 21821568 — intervention group
Group type: COMPARATOR
Intervention: Control group (facilities not financed by performance-based subsidies)
Number of subjects: 0
Study 19081414 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial PCI with maximal antiplatelet therapy (clopidogrel and abciximab)
Number of subjects: 1348
Study 19081414 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with major bleeding
Number of subjects: 1348
Study 19081414 — intervention group
Group type: EXPERIMENTAL
Intervention: Major bleeding
Number of subjects: 1348
Study 16395748 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg infliximab
Number of subjects: 147
Study 16395748 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg infliximab
Number of subjects: 147
Study 16395748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 16395748 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (DBT)
Number of subjects: 147
Study 16395748 — intervention group
Group type: COMPARATOR
Intervention: Placebo (DBT)
Number of subjects: 147
Study 15537996 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with standard rehabilitation
Number of subjects: 32
Study 15537996 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation
Number of subjects: 32
Study 10968358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 275
Study 9231892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of verapamil slow release (SR) and trandolapril, administered for 8 weeks
Number of subjects: 0
Study 9231892 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1490497 — intervention group
Group type: EXPERIMENTAL
Intervention: Parlodel SRO
Number of subjects: 34
Study 1490497 — intervention group
Group type: COMPARATOR
Intervention: Parlodel standard
Number of subjects: 34
Study 3884766 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment (prednisone plus azathioprine)
Number of subjects: 15
Study 3884766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31004493 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive multi-component (PMC) intervention including lower extremity resistance training at 80% of a 1-repetition maximum, task-specific activities of daily living training, advanced gait and balance training, nutritional supplementation, and nursing support during transition from hospital to home
Number of subjects: 200
Study 31004493 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) physical therapy
Number of subjects: 200
Study 30348145 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 RA therapy
Number of subjects: 559
Study 28002471 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 2.5 mg/kg/day for neonates born at less than 32 weeks of GA (n = 30)
Number of subjects: 54
Study 28002471 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 1 mg/kg/day for neonates born at more than 32 weeks of GA (n = 24)
Number of subjects: 54
Study 24438077 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush (ET)
Number of subjects: 180
Study 24438077 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (MT)
Number of subjects: 180
Study 24438077 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver opinion on ET
Number of subjects: 180
Study 22158142 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-SET
Number of subjects: 3
Study 22158142 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-SET
Number of subjects: 3
Study 22158142 — intervention group
Group type: COMPARATOR
Intervention: 1-SET
Number of subjects: 3
Study 20675920 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular physical training (highly trained athletes)
Number of subjects: 24
Study 20675920 — intervention group
Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 24
Study 17414239 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 254
Study 17414239 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 254
Study 17414239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 17414239 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram and Naltrexone
Number of subjects: 254
Study 17414239 — intervention group
Group type: COMPARATOR
Intervention: Disulfiram and Placebo
Number of subjects: 254
Study 16368032 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions (cognitive behaviour therapy, counselling)
Number of subjects: 192
Study 16368032 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling
Number of subjects: 192
Study 16368032 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention (one‐to‐one delivery)
Number of subjects: 192
Study 16368032 — intervention group
Group type: COMPARATOR
Intervention: Routine primary care
Number of subjects: 192
Study 12163777 — intervention group
Group type: EXPERIMENTAL
Intervention: Early hemodynamic optimization (goals: cardiac index >4.5 L x min(‐1) x m(‐2), pulmonary artery occlusion pressure <18 mm Hg, oxygen delivery >600 mL x min(‐1) x m(‐2), oxygen consumption >170 mL x min(‐1) x m(‐2))
Number of subjects: 21
Study 12163777 — intervention group
Group type: EXPERIMENTAL
Intervention: Late hemodynamic optimization (after organ failure)
Number of subjects: 21
Study 12163777 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal values as goals or therapy that did not improve oxygen delivery
Number of subjects: 21
Study 9797239 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cidofovir gel
Number of subjects: 96
Study 9797239 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% cidofovir gel
Number of subjects: 96
Study 9797239 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% cidofovir gel
Number of subjects: 96
Study 9797239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 7705123 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesna (3 mL)
Number of subjects: 20
Study 7705123 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (3 mL)
Number of subjects: 20
Study 2768152 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 4
Study 2768152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 2768152 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (highest dose)
Number of subjects: 4
Study 2768152 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (lower dose)
Number of subjects: 4
Study 861124 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 20
Study 861124 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg
Number of subjects: 20
Study 861124 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam 2.5 mg
Number of subjects: 20
Study 861124 — intervention group
Group type: COMPARATOR
Intervention: Lactose (dummy control)
Number of subjects: 20
Study 31435922 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonoporation (CEUS-IGDD)
Number of subjects: 10
Study 31435922 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapeutics
Number of subjects: 10
Study 30942552 — intervention group
Group type: EXPERIMENTAL
Intervention: AEX + TST
Number of subjects: 20
Study 30942552 — intervention group
Group type: COMPARATOR
Intervention: TST
Number of subjects: 20
Study 27613951 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco Heating System 2.1 (THS 2.1)
Number of subjects: 40
Study 27613951 — intervention group
Group type: COMPARATOR
Intervention: Combustible Cigarettes (CC)
Number of subjects: 40
Study 26437502 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (All Bond 3)
Number of subjects: 204
Study 26437502 — intervention group
Group type: COMPARATOR
Intervention: Group B (Clearfil Protect Bond)
Number of subjects: 204
Study 23541711 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mg Zolpidem Sublingual Tablet (ZST)
Number of subjects: 33
Study 23541711 — intervention group
Group type: COMPARATOR
Intervention: 10 mg Immediate-Release (IR) Oral Zolpidem
Number of subjects: 33
Study 21860242 — intervention group
Group type: EXPERIMENTAL
Intervention: GSE (proanthocyanidin-rich grape seed extract)
Number of subjects: 0
Study 21860242 — intervention group
Group type: EXPERIMENTAL
Intervention: GSE+F (GSE with fluoride)
Number of subjects: 0
Study 21860242 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride (F)
Number of subjects: 0